Form 4: Repare Therapeutics Director Acquires Stock Options

Director Susan Molineaux acquired stock options for 27,200 common shares of Repare Therapeutics Inc. on June 17, 2024.

Summary

• Susan Molineaux, a director of Repare Therapeutics Inc., acquired stock options on June 17, 2024.
• The options grant the right to buy 27,200 common shares at an exercise price of $3.80.
• The options vest in equal monthly installments over twelve months from the grant date, contingent upon continued service.
• Following the transaction, Molineaux directly owns 27,200 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and the sentiment is neutral. It simply reports a transaction.

Positives

• The acquisition of stock options by a director signals confidence in the company's future performance.

Industry Context

This is a standard Form 4 filing, reflecting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company directors and officers.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's belief in the company's future.

Key Dates